Related references
Note: Only part of the references are listed.Reduced Right Ventricular Sarcomere Contractility in Heart Failure With Preserved Ejection Fraction and Severe Obesity
M. Imran Aslam et al.
CIRCULATION (2021)
Myocardial Gene Expression Signatures in Human Heart Failure With Preserved Ejection Fraction
Virginia S. Hahn et al.
CIRCULATION (2021)
Pulmonary hypertension and right ventricular remodeling in HFpEF and HFrEF
Stefano Ghio et al.
HEART FAILURE REVIEWS (2020)
Optimizing The Management of Obese HFpEF Phenotype: Can We Mind Both The Heart and The Kidney?
Bharathi Upadhya et al.
JOURNAL OF CARDIAC FAILURE (2020)
Myocardial Phosphodiesterases and Their Role in cGMP Regulation
Brittany Dunkerly-Eyring et al.
JOURNAL OF CARDIOVASCULAR PHARMACOLOGY (2020)
Prior Heart Failure Hospitalization, Clinical Outcomes, and Response to Sacubitril/Valsartan Compared With Valsartan in HFpEF
Muthiah Vaduganathan et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2020)
IL-11 in cardiac and renal fibrosis: Late to the party but a central player
Benjamin Corden et al.
BRITISH JOURNAL OF PHARMACOLOGY (2020)
Mechanistic Effects of Spironolactone on Cardiovascular and Renal Biomarkers in Heart Failure With Preserved Ejection Fraction A TOPCAT Biorepository Study
Peder L. Myhre et al.
CIRCULATION-HEART FAILURE (2020)
Endothelium-dependent and independent coronary microvascular dysfunction in patients with heart failure with preserved ejection fraction
Jeong Hoon Yang et al.
EUROPEAN JOURNAL OF HEART FAILURE (2020)
Identification of novel pheno-groups in heart failure with preserved ejection fraction using machine learning
Asa K. Hedman et al.
HEART (2020)
Site-specific acetyl-mimetic modification of cardiac troponin I modulates myofilament relaxation and calcium sensitivity
Ying H. Lin et al.
JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY (2020)
Unfolding Discoveries in Heart Failure
Walter J. Paulus
NEW ENGLAND JOURNAL OF MEDICINE (2020)
A new algorithm for optimization of rate-adaptive pacing improves exercise tolerance in patients with HFpEF
Maria Serova et al.
PACE-PACING AND CLINICAL ELECTROPHYSIOLOGY (2020)
HDAC inhibition improves cardiopulmonary function in a feline model of diastolic dysfunction
Markus Wallner et al.
SCIENCE TRANSLATIONAL MEDICINE (2020)
Rationale and design for a multicenter, randomized, double-blind, placebo- controlled, phase 2 study evaluating the safety and efficacy of the soluble guanylate cyclase stimulator praliciguat over 12 weeks in patients with heart failure with preserved ejection fraction (CAPACITY HFpEF)
James E. Udelson et al.
AMERICAN HEART JOURNAL (2020)
Research Priorities for Heart Failure With Preserved Ejection Fraction National Heart, Lung, and Blood Institute Working Group Summary
Sanjiv J. Shah et al.
CIRCULATION (2020)
Covariate adjusted reanalysis of the I-Preserve trial
Joao Pedro Ferreira et al.
CLINICAL RESEARCH IN CARDIOLOGY (2020)
Therapeutic approaches in heart failure with preserved ejection fraction: past, present, and future
Jan Wintrich et al.
CLINICAL RESEARCH IN CARDIOLOGY (2020)
Clinical Phenogroups in Heart Failure With Preserved Ejection Fraction Detailed Phenotypes, Prognosis, and Response to Spironolactone
Jordana B. Cohen et al.
JACC-HEART FAILURE (2020)
Multiple Plasma Biomarkers for Risk Stratification in Patients With Heart Failure and Preserved Ejection Fraction
Julio A. Chirinos et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2020)
Treatment With Treprostinil and Metformin Normalizes Hyperglycemia and Improves Cardiac Function in Pulmonary Hypertension Associated With Heart Failure With Preserved Ejection Fraction
Longfei Wang et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2020)
Extended-Release Oral Milrinone for the Treatment of Heart Failure With Preserved Ejection Fraction
Shane Nanayakkara et al.
JOURNAL OF THE AMERICAN HEART ASSOCIATION (2020)
Endomyocardial Biopsy Characterization of Heart Failure With Preserved Ejection Fraction and Prevalence of Cardiac Amyloidosis
Virginia S. Hahn et al.
JACC-HEART FAILURE (2020)
Proteomic Evaluation of the Comorbidity-Inflammation Paradigm in Heart Failure With Preserved Ejection Fraction Results From the PROMIS-HFpEF Study
Sandra Sanders-van Wijk et al.
CIRCULATION (2020)
Cardiovascular and Renal Outcomes with Empagliflozin in Heart Failure
Milton Packer et al.
NEW ENGLAND JOURNAL OF MEDICINE (2020)
Estrogen Receptor-α Non-Nuclear Signaling Confers Cardioprotection and Is Essential to cGMP-PDE5 Inhibition Efficacy
Nobuaki Fukuma et al.
JACC-BASIC TO TRANSLATIONAL SCIENCE (2020)
Peripheral Determinants of Oxygen Utilization in Heart Failure With Preserved Ejection Fraction Central Role of Adiposity
Payman Zamani et al.
JACC-BASIC TO TRANSLATIONAL SCIENCE (2020)
Heart failure with preserved ejection fraction in Asia
Jasper Tromp et al.
EUROPEAN JOURNAL OF HEART FAILURE (2019)
Increased ketone body oxidation provides additional energy for the failing heart without improving cardiac efficiency
Kim L. Ho et al.
CARDIOVASCULAR RESEARCH (2019)
Heart Failure With Preserved Ejection Fraction Infrequently Evolves Toward a Reduced Phenotype in Long-Term Survivors A Long-Term Prospective Longitudinal Study
Josep Lupon et al.
CIRCULATION-HEART FAILURE (2019)
CaMKII signaling in heart diseases: Emerging role in diabetic cardiomyopathy
Bence Hegyi et al.
JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY (2019)
Heart Failure With Preserved Ejection Fraction and Diabetes JACC State-of-the-Art Review
Kelly McHugh et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2019)
Combining Circulating MicroRNA and NT-proBNP to Detect and Categorize Heart Failure Subtypes
Lee Lee Wong et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2019)
PKG1-modified TSC2 regulates mTORC1 activity to counter adverse cardiac stress
Mark J. Ranek et al.
NATURE (2019)
Relationship Between Focal and Diffuse Fibrosis Assessed by CMR and Clinical Outcomes in Heart Failure With Preserved Ejection Fraction
Prathap Kanagala et al.
JACC-CARDIOVASCULAR IMAGING (2019)
The Impact of APOL1 on Chronic Kidney Disease and Hypertension
Todd W. Robinson et al.
ADVANCES IN CHRONIC KIDNEY DISEASE (2019)
Cardiorenal syndrome in heart failure with preserved ejection fractionan under-recognized clinical entity
Akanksha Agrawal et al.
HEART FAILURE REVIEWS (2019)
Pulmonary vascular disease in the setting of heart failure with preserved ejection fraction
Andrea R. Levine et al.
TRENDS IN CARDIOVASCULAR MEDICINE (2019)
Exercise Intolerance in Patients With Heart Failure
Marco Giuseppe Del Buono et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2019)
Nitrosative stress drives heart failure with preserved ejection fraction
Gabriele G. Schiattarella et al.
NATURE (2019)
In vivo selective inhibition of TRPC6 by antagonist BI 749327 ameliorates fibrosis and dysfunction in cardiac and renal disease
Brian Leei Lin et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2019)
Arterial Remodeling and Dysfunction in the ZSF1 Rat Model of Heart Failure With Preserved Ejection Fraction
Sara Leite et al.
CIRCULATION-HEART FAILURE (2019)
Rationale and design of the EMPERIAL-Preserved and EMPERIAL-Reduced trials of empagliflozin in patients with chronic heart failure
William T. Abraham et al.
EUROPEAN JOURNAL OF HEART FAILURE (2019)
Inflammation in nonischemic heart disease: initiation by cardiomyocyte CaMKII and NLRP3 inflammasome signaling
Takeshi Suetomi et al.
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY (2019)
Hippo pathway deletion in adult resting cardiac fibroblasts initiates a cell state transition with spontaneous and self-sustaining fibrosis
Yang Xiao et al.
GENES & DEVELOPMENT (2019)
CaMKII Activity in the Inflammatory Response of Cardiac Diseases
Maria Rosaria Rusciano et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2019)
Angiotensin-Neprilysin Inhibition in Heart Failure with Preserved Ejection Fraction
S. D. Solomon et al.
NEW ENGLAND JOURNAL OF MEDICINE (2019)
Chronic Kidney Disease as a Risk Factor for Heart Failure With Preserved Ejection Fraction: A Focus on Microcirculatory Factors and Therapeutic Targets
Jens van de Wouw et al.
FRONTIERS IN PHYSIOLOGY (2019)
Female Sex Is Protective in a Preclinical Model of Heart Failure With Preserved Ejection Fraction
Dan Tong et al.
CIRCULATION (2019)
Myocardial Energetics in Heart Failure With Preserved Ejection Fraction
Omar F. AbouEzzeddine et al.
CIRCULATION-HEART FAILURE (2019)
Is Heart Failure with Preserved Ejection Fraction a Kidney Disorder?
Kevin S. Shah et al.
CURRENT HYPERTENSION REPORTS (2019)
Mitochondrial NAD+/NADH Redox State and Diabetic Cardiomyopathy
Jessica M. Berthiaume et al.
ANTIOXIDANTS & REDOX SIGNALING (2019)
Microvascular Dysfunction in Heart Failure With Preserved Ejection Fraction
Domenico D'Amario et al.
FRONTIERS IN PHYSIOLOGY (2019)
The β-Adrenergic Agonist Albuterol Improves Pulmonary Vascular Reserve in Heart Failure With Preserved Ejection Fraction A Randomized Controlled Trial
Yogesh N. V. Reddy et al.
CIRCULATION RESEARCH (2019)
Deterioration in right ventricular structure and function over time in patients with heart failure and preserved ejection fraction
Masaru Obokata et al.
EUROPEAN HEART JOURNAL (2019)
Heart Failure with Reduced Ejection Fraction (HFrEF) and Preserved Ejection Fraction (HFpEF): The Diagnostic Value of Circulating MicroRNAs
Yei-Tsung Chen et al.
CELLS (2019)
Metabolic Profiling of the Diabetic Heart: Toward a Richer Picture
Alice P. Sowton et al.
FRONTIERS IN PHYSIOLOGY (2019)
Microvascular Rarefaction and Heart Failure With Preserved Ejection Fraction
Heng Zeng et al.
FRONTIERS IN CARDIOVASCULAR MEDICINE (2019)
Natriuretic peptide receptor C contributes to disproportionate right ventricular hypertrophy in a rodent model of obesity-induced heart failure with preserved ejection fraction with pulmonary hypertension
Vineet Agrawal et al.
PULMONARY CIRCULATION (2019)
Coronary microvascular dysfunction and future risk of heart failure with preserved ejection fraction
Viviany R. Taqueti et al.
EUROPEAN HEART JOURNAL (2018)
Right heart dysfunction and failure in heart failure with preserved ejection fraction: mechanisms and management. Position statement on behalf of the Heart Failure Association of the European Society of Cardiology
Thomas M. Gorter et al.
EUROPEAN JOURNAL OF HEART FAILURE (2018)
Bariatric Surgery-Induced Cardiac and Lipidomic Changes in Obesity-Related Heart Failure with Preserved Ejection Fraction
Deana Mikhalkova et al.
OBESITY (2018)
Effect of Spironolactone on Myocardial Fibrosis and Other Clinical Variables in Patients with Hypertrophic Cardiomyopathy
Martin S. Maron et al.
AMERICAN JOURNAL OF MEDICINE (2018)
Characterization of a mouse model of obesity-related fibrotic cardiomyopathy that recapitulates features of human heart failure with preserved ejection fraction
Linda Alex et al.
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY (2018)
Multiple common comorbidities produce left ventricular diastolic dysfunction associated with coronary microvascular dysfunction, oxidative stress, and myocardial stiffening
Oana Sorop et al.
CARDIOVASCULAR RESEARCH (2018)
A Simple, Evidence-Based Approach to Help Guide Diagnosis of Heart Failure With Preserved Ejection Fraction
Yogesh N. V. Reddy et al.
CIRCULATION (2018)
Diabetes-Induced Cardiomyocyte Passive Stiffening Is Caused by Impaired Insulin-Dependent Titin Modification and Can Be Modulated by Neuregulin-1
Anna-Eliane Hopf et al.
CIRCULATION RESEARCH (2018)
Diabetic Cardiomyopathy: An Update of Mechanisms Contributing to This Clinical Entity
Guanghong Jia et al.
CIRCULATION RESEARCH (2018)
Mortality associated with heart failure with preserved vs. reduced ejection fraction in a prospective internationalmulti-ethnic cohort study
Carolyn S. P. Lam et al.
EUROPEAN HEART JOURNAL (2018)
Exercise unmasks distinct pathophysiologic features in heart failure with preserved ejection fraction and pulmonary vascular disease
Thomas M. Gorter et al.
EUROPEAN HEART JOURNAL (2018)
Biomarker-based phenotyping of myocardial fibrosis identifies patients with heart failure with preserved ejection fraction resistant to the beneficial effects of spironolactone: results from the Aldo-DHF trial
Susana Ravassa et al.
EUROPEAN JOURNAL OF HEART FAILURE (2018)
Heart failure with preserved ejection fraction: controversies, challenges and future directions
Rosita Zakeri et al.
HEART (2018)
Mechanisms of the Improvement in Peak VO2 With Exercise Training in Heart Failure With Reduced or Preserved Ejection Fraction
Wesley J. Tucker et al.
HEART LUNG AND CIRCULATION (2018)
Captopril Attenuates Cardiovascular and Renal Disease in a Rat Model of Heart Failure With Preserved Ejection Fraction
Eman M. Salah et al.
JOURNAL OF CARDIOVASCULAR PHARMACOLOGY (2018)
Dynamics of fibroblast activation in the infarcted heart
Alexandra Le Bras
NATURE REVIEWS CARDIOLOGY (2018)
Defining the molecular signatures of human right heart failure
Jordan L. Williams et al.
LIFE SCIENCES (2018)
Uncoupling of glycolysis from glucose oxidation accompanies the development o heart failure with preserved ejection fraction
Natasha Fillmore et al.
MOLECULAR MEDICINE (2018)
Nitric oxide signalling in cardiovascular health and disease
Charlotte Farah et al.
NATURE REVIEWS CARDIOLOGY (2018)
Mechanisms of physiological and pathological cardiac hypertrophy
Michinari Nakamura et al.
NATURE REVIEWS CARDIOLOGY (2018)
Cardiac metabolism - A promising therapeutic target for heart failure
Hannah Noordali et al.
PHARMACOLOGY & THERAPEUTICS (2018)
Histone deacetylase activity governs diastolic dysfunction through a nongenomic mechanism
Mark Y. Jeong et al.
SCIENCE TRANSLATIONAL MEDICINE (2018)
Heart Failure with Preserved Ejection Fraction
James D. Gladden et al.
ANNUAL REVIEW OF MEDICINE, VOL 69 (2018)
High Right Ventricular Stroke Work Index Is Associated with Worse Kidney Function in Patients with Heart Failure with Preserved Ejection Fraction
Napatt Kanjanahattakij et al.
CARDIORENAL MEDICINE (2018)
Pro-Inflammatory Biomarkers in Stable Versus Acutely Decompensated Heart Failure With Preserved Ejection Fraction
Abraham Abernethy et al.
JOURNAL OF THE AMERICAN HEART ASSOCIATION (2018)
Association of APOL1 With Heart Failure With Preserved Ejection Fraction in Postmenopausal African American Women
Nora Franceschini et al.
JAMA CARDIOLOGY (2018)
Association of Cardiovascular Biomarkers With Incident Heart Failure With Preserved and Reduced Ejection Fraction
Rudolf A. de Boer et al.
JAMA CARDIOLOGY (2018)
Nicotinamide Riboside Preserves Cardiac Function in a Mouse Model of Dilated Cardiomyopathy
Nicolas Diguet et al.
CIRCULATION (2018)
Transcatheter Interatrial Shunt Device for the Treatment of Heart Failure With Preserved Ejection Fraction (REDUCE LAP-HF I [Reduce Elevated Left Atrial Pressure in Patients With Heart Failure]): A Phase 2, Randomized, Sham-Controlled Trial
Ted Feldman et al.
CIRCULATION (2018)
Global Pulmonary Vascular Remodeling in Pulmonary Hypertension Associated With Heart Failure and Preserved or Reduced Ejection Fraction
Ahmed U. Fayyaz et al.
CIRCULATION (2018)
IL-1 Blockade in Patients With Heart Failure With Preserved Ejection Fraction: Results From DHART2
Benjamin W. Van Tassell et al.
CIRCULATION-HEART FAILURE (2018)
Effects of Endurance Training on Detrimental Structural, Cellular, and Functional Alterations in Skeletal Muscles of Heart Failure With Preserved Ejection Fraction
T. Scott Bowen et al.
JOURNAL OF CARDIAC FAILURE (2018)
High-sensitivity C-reactive protein in heart failure with preserved ejection fraction
Hilary M. DuBrock et al.
PLOS ONE (2018)
Plasma levels of heart failure biomarkers are primarily a reflection of extracardiac production
Weijie Du et al.
THERANOSTICS (2018)
Weighty Matters in HFpEF and Aging
Daniel E. Forman et al.
JACC-HEART FAILURE (2018)
Randomized Evaluation of Heart Failure With Preserved Ejection Fraction Patients With Acute Heart Failure and Dopamine The ROPA-DOP Trial
Kavita Sharma et al.
JACC-HEART FAILURE (2018)
Inflammation and NLRP3 Inflammasome Activation Initiated in Response to Pressure Overload by Ca2+/Calmodulin-Dependent Protein Kinase II Signaling in Cardiomyocytes Are Essential for Adverse Cardiac Remodeling
Takeshi Suetomi et al.
CIRCULATION (2018)
Effect of Inorganic Nitrite vs Placebo on Exercise Capacity Among Patients With Heart Failure With Preserved Ejection Fraction The INDIE-HFpEF Randomized Clinical Trial
Barry A. Borlaug et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2018)
Heart rate response and functional capacity in patients with chronic heart failure with preserved ejection fraction
Eloy Dominguez et al.
ESC HEART FAILURE (2018)
Loss of Metabolic Flexibility in the Failing Heart
Qutuba G. Karwi et al.
FRONTIERS IN CARDIOVASCULAR MEDICINE (2018)
Diabetes with heart failure increases methylglyoxal modifications in the sarcomere, which inhibit function
Maria Papadaki et al.
JCI INSIGHT (2018)
Specialized fibroblast differentiated states underlie scar formation in the infarcted mouse heart
Xing Fu et al.
JOURNAL OF CLINICAL INVESTIGATION (2018)
CCR2+ Monocyte-Derived Infiltrating Macrophages Are Required for Adverse Cardiac Remodeling During Pressure Overload
Bindiya Patel et al.
JACC-BASIC TO TRANSLATIONAL SCIENCE (2018)
The interplay between metabolic alterations, diastolic strain rate and exercise capacity in mild heart failure with preserved ejection fraction: a cardiovascular magnetic resonance study
Masliza Mahmod et al.
JOURNAL OF CARDIOVASCULAR MAGNETIC RESONANCE (2018)
Vericiguat in patients with worsening chronic heart failure and preserved ejection fraction: results of the SOluble guanylate Cyclase stimulatoR in heArT failurE patientS with PRESERVED EF (SOCRATES-PRESERVED) study
Burkert Pieske et al.
EUROPEAN HEART JOURNAL (2017)
The prognostic value of highly sensitive cardiac troponin assays for adverse events in men and women with stable heart failure and a preserved vs. reduced ejection fraction
Aisha Gohar et al.
EUROPEAN JOURNAL OF HEART FAILURE (2017)
Effect of ivabradine in patients with heart failure with preserved ejection fraction: the EDIFY randomized placebo-controlled trial
Michel Komajda et al.
EUROPEAN JOURNAL OF HEART FAILURE (2017)
Skeletal muscle inflammation and insulin resistance in obesity
Huaizhu Wu et al.
JOURNAL OF CLINICAL INVESTIGATION (2017)
Endothelial specific SIRT3 deletion impairs glycolysis and angiogenesis and causes diastolic dysfunction
Xiaochen He et al.
JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY (2017)
The diabetic heart utilizes ketone bodies as an energy source
Yuji Mizuno et al.
METABOLISM-CLINICAL AND EXPERIMENTAL (2017)
Spironolactone Metabolites in TOPCAT - New Insights into Regional Variation
Simon de Denus et al.
NEW ENGLAND JOURNAL OF MEDICINE (2017)
Cardiac oxidative stress in diabetes: Mechanisms and therapeutic potential
Alyssa Faria et al.
PHARMACOLOGY & THERAPEUTICS (2017)
T cell costimulation blockade blunts pressure overload-induced heart failure
Marinos Kallikourdis et al.
NATURE COMMUNICATIONS (2017)
Inflammatory Biomarkers Predict Heart Failure Severity and Prognosis in Patients With Heart Failure With Preserved Ejection Fraction A Holistic Proteomic Approach
Camilla Hage et al.
CIRCULATION-CARDIOVASCULAR GENETICS (2017)
Heart Failure with Preserved Ejection Fraction and Future Pharmacological Strategies: a Glance in the Crystal Ball
Carsten Tschoepe et al.
CURRENT CARDIOLOGY REPORTS (2017)
Factors Associated With and Prognostic Implications of Cardiac Troponin Elevation in Decompensated Heart Failure With Preserved Ejection Fraction Findings From the American Heart Association Get With The Guidelines-Heart Failure Program
Ambarish Pandey et al.
JAMA CARDIOLOGY (2017)
Percutaneous Pericardial Resection A Novel Potential Treatment for Heart Failure With Preserved Ejection Fraction
Barry A. Borlaug et al.
CIRCULATION-HEART FAILURE (2017)
Effect of bariatric surgery on heart failure
Marcela Rodriguez Flores et al.
EXPERT REVIEW OF CARDIOVASCULAR THERAPY (2017)
Effects of renal denervation on vascular remodelling in patients with heart failure and preserved ejection fraction: A randomised control trial
Hitesh C. Patel et al.
JRSM CARDIOVASCULAR DISEASE (2017)
Fatigability, Exercise Intolerance, and Abnormal Skeletal Muscle Energetics in Heart Failure
Kilian Weiss et al.
CIRCULATION-HEART FAILURE (2017)
Evidence Supporting the Existence of a Distinct Obese Phenotype of Heart Failure With Preserved Ejection Fraction
Masaru Obokata et al.
CIRCULATION (2017)
Growth differentiation factor 15 in heart failure with preserved vs. reduced ejection fraction
Michelle M. Y. Chan et al.
EUROPEAN JOURNAL OF HEART FAILURE (2016)
Evidence of microvascular dysfunction in heart failure with preserved ejection fraction
Joshua F. Lee et al.
HEART (2016)
Diagnostic significance of serum galectin-3 levels in heart failure with preserved ejection fraction
Veli Polat et al.
ACTA CARDIOLOGICA (2016)
Myocardial steatosis as a possible mechanistic link between diastolic dysfunction and coronary microvascular dysfunction in women
Janet Wei et al.
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY (2016)
Atrial remodelling in atrial fibrillation: CaMKII as a nodal proarrhythmic signal
Olurotimi O. Mesubi et al.
CARDIOVASCULAR RESEARCH (2016)
Normalization of NAD+ Redox Balance as a Therapy for Heart Failure
Chi Fung Lee et al.
CIRCULATION (2016)
SIRT3-AMP-Activated Protein Kinase Activation by Nitrite and Metformin Improves Hyperglycemia and Normalizes Pulmonary Hypertension Associated With Heart Failure With Preserved Ejection Fraction
Yen-Chun Lai et al.
CIRCULATION (2016)
The Failing Heart Relies on Ketone Bodies as a Fuel
Gregory Aubert et al.
CIRCULATION (2016)
CV Protection in the EMPA-REG OUTCOME Trial: A Thrifty Substrate Hypothesis
Ele Ferrannini et al.
DIABETES CARE (2016)
Abnormal right ventricular-pulmonary artery coupling with exercise in heart failure with preserved ejection fraction
Barry A. Borlaug et al.
EUROPEAN HEART JOURNAL (2016)
Novel pathomechanisms of cardiomyocyte dysfunction in a model of heart failure with preserved ejection fraction
Uwe Primessnig et al.
EUROPEAN JOURNAL OF HEART FAILURE (2016)
Redox signaling in the cardiomyocyte: From physiology to failure
Celio X. C. Santos et al.
INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY (2016)
Vascular and Microvascular Endothelial Function in Heart Failure With Preserved Ejection Fraction
Sylvestre Marechaux et al.
JOURNAL OF CARDIAC FAILURE (2016)
Effects of Milrinone on Rest and Exercise Hemodynamics in Heart Failure With Preserved Ejection Fraction
David M. Kaye et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2016)
The HFpEF Obesity Phenotype The Elephant in the Room
Dalane W. Kitzman et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2016)
Metabolomic Profiling Identifies Novel Circulating Biomarkers of Mitochondrial Dysfunction Differentially Elevated in Heart Failure With Preserved Versus Reduced Ejection Fraction: Evidence for Shared Metabolic Impairments in Clinical Heart Failure
Wynn G. Hunter et al.
JOURNAL OF THE AMERICAN HEART ASSOCIATION (2016)
Skeletal Muscle Mitochondrial Content, Oxidative Capacity, and Mfn2 Expression Are Reduced in Older Patients With Heart Failure and Preserved Ejection Fraction and Are Related to Exercise Intolerance
Anthony J. A. Molina et al.
JACC-HEART FAILURE (2016)
Impaired Pulmonary Diffusion in Heart Failure With Preserved Ejection Fraction
Thomas P. Olson et al.
JACC-HEART FAILURE (2016)
Myocardial Microvascular Inflammatory Endothelial Activation in Heart Failure With Preserved Ejection Fraction
Constantijn Franssen et al.
JACC-HEART FAILURE (2016)
Diffusion Capacity and Mortality in Patients With Pulmonary Hypertension Due to Heart Failure With Preserved Ejection Fraction
Marius M. Hoeper et al.
JACC-HEART FAILURE (2016)
A Soluble Guanylate Cyclase Activator Inhibits the Progression of Diabetic Nephropathy in the ZSF1 Rat
Carine M. Boustany-Kari et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2016)
Early-stage heart failure with preserved ejection fraction in the pig: a cardiovascular magnetic resonance study
Ursula Reiter et al.
JOURNAL OF CARDIOVASCULAR MAGNETIC RESONANCE (2016)
Exercise training in chronic heart failure: improving skeletal muscle O2 transport and utilization
Daniel M. Hirai et al.
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY (2015)
A porcine model of hypertensive cardiomyopathy: implications for heart failure with preserved ejection fraction
Michael Schwarzl et al.
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY (2015)
The cGMP/PKG pathway as a common mediator of cardioprotection: translatability and mechanism
Javier Inserte et al.
BRITISH JOURNAL OF PHARMACOLOGY (2015)
Pulmonary Hypertension Secondary to Heart Failure With Preserved Ejection Fraction
Thenappan Thenappan et al.
CANADIAN JOURNAL OF CARDIOLOGY (2015)
Effect of Selective Heart Rate Slowing in Heart Failure With Preserved Ejection Fraction
Nikhil Pal et al.
CIRCULATION (2015)
Myocardial Stiffness in Patients With Heart Failure and a Preserved Ejection Fraction Contributions of Collagen and Titin
Michael R. Zile et al.
CIRCULATION (2015)
Upregulation of MG53 Induces Diabetic Cardiomyopathy Through Transcriptional Activation of Peroxisome Proliferation-Activated Receptor α
Fenghua Liu et al.
CIRCULATION (2015)
Role of biomarkers in cardiac structure phenotyping in heart failure with preserved ejection fraction: critical appraisal and practical use
Emilia D'Elia et al.
EUROPEAN JOURNAL OF HEART FAILURE (2015)
Circulating biomarkers of distinct pathophysiological pathways in heart failure with preserved vs. reduced left ventricular ejection fraction
Sandra Sanders-van Wijk et al.
EUROPEAN JOURNAL OF HEART FAILURE (2015)
Circulating microRNAs in heart failure with reduced and preserved left ventricular ejection fraction
Lee Lee Wong et al.
EUROPEAN JOURNAL OF HEART FAILURE (2015)
Determinants of exercise intolerance in patients with heart failure and reduced or preserved ejection fraction
Mark J. Haykowsky et al.
JOURNAL OF APPLIED PHYSIOLOGY (2015)
Phosphodiesterase 9A controls nitric-oxide-independent cGMP and hypertrophic heart disease
Dong I. Lee et al.
NATURE (2015)
Myocardial pressure overload induces systemic inflammation through endothelial cell IL-33
Wei-Yu Chen et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2015)
Metabolomic Fingerprint of Heart Failure with Preserved Ejection Fraction
Beshay N. Zordoky et al.
PLOS ONE (2015)
Exercise Training in Patients With Heart Failure and Preserved Ejection Fraction Meta-Analysis of Randomized Control Trials
Ambarish Pandey et al.
CIRCULATION-HEART FAILURE (2015)
Mechanisms of Exercise Intolerance in Heart Failure With Preserved Ejection Fraction The Role of Abnormal Peripheral Oxygen Extraction
Bishnu P. Dhakal et al.
CIRCULATION-HEART FAILURE (2015)
Coronary Microvascular Rarefaction and Myocardial Fibrosis in Heart Failure With Preserved Ejection Fraction
Selma F. Mohammed et al.
CIRCULATION (2015)
Skeletal Muscle Composition and Its Relation to Exercise Intolerance in Older Patients With Heart Failure and Preserved Ejection Fraction
Mark J. Haykowsky et al.
AMERICAN JOURNAL OF CARDIOLOGY (2014)
Skeletal muscle abnormalities and exercise intolerance in older patients with heart failure and preserved ejection fraction
Dalane W. Kitzman et al.
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY (2014)
CD4+ T Cells Promote the Transition From Hypertrophy to Heart Failure During Chronic Pressure Overload
Fanny Laroumanie et al.
CIRCULATION (2014)
Right Ventricular Function in Heart Failure With Preserved Ejection Fraction A Community-Based Study
Selma F. Mohammed et al.
CIRCULATION (2014)
Resting Ventricular-Vascular Function and Exercise Capacity in Heart Failure With Preserved Ejection Fraction A RELAX Trial Ancillary Study
Selma F. Mohammed et al.
CIRCULATION-HEART FAILURE (2014)
Left Ventricular Mass and Hypertrophy by Echocardiography and Cardiac Magnetic Resonance: The Multi-Ethnic Study of Atherosclerosis
Anderson C. Armstrong et al.
ECHOCARDIOGRAPHY-A JOURNAL OF CARDIOVASCULAR ULTRASOUND AND ALLIED TECHNIQUES (2014)
Right heart dysfunction in heart failure with preserved ejection fraction
Vojtech Melenovsky et al.
EUROPEAN HEART JOURNAL (2014)
PDE5 inhibitor efficacy is estrogen dependent in female heart disease
Hideyuki Sasaki et al.
JOURNAL OF CLINICAL INVESTIGATION (2014)
Cardiovascular Phenotype in HFpEF Patients With or Without Diabetes A RELAX Trial Ancillary Study
Brian R. Lindman et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2014)
A heart-adipose tissue connection in the regulation of energy metabolism
Sheila Collins
NATURE REVIEWS ENDOCRINOLOGY (2014)
Spironolactone for Heart Failure with Preserved Ejection Fraction
Bertram Pitt et al.
NEW ENGLAND JOURNAL OF MEDICINE (2014)
Angiotensin-Neprilysin Inhibition versus Enalapril in Heart Failure
John J. V. McMurray et al.
NEW ENGLAND JOURNAL OF MEDICINE (2014)
Circulating Levels of Tumor Necrosis Factor-Alpha Receptor 2 Are Increased in Heart Failure with Preserved Ejection Fraction Relative to Heart Failure with Reduced Ejection Fraction: Evidence for a Divergence in Pathophysiology
Brendan N. Putko et al.
PLOS ONE (2014)
Obesity, metabolic dysfunction, and cardiac fibrosis: pathophysiological pathways, molecular mechanisms, and therapeutic opportunities
Michele Cavalera et al.
TRANSLATIONAL RESEARCH (2014)
Ketone bodies as signaling metabolites
John C. Newman et al.
TRENDS IN ENDOCRINOLOGY AND METABOLISM (2014)
Randomized double-blind placebocontrolled trial of perhexiline in heart failure with preserved ejection fraction syndrome
Satnam Singh et al.
FUTURE CARDIOLOGY (2014)
Preconditioning with soluble guanylate cyclase activation prevents postischemic inflammation and reduces nitrate tolerance in heme oxygenase-1 knockout mice
Walter Z. Wang et al.
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY (2013)
Targeting mitochondrial oxidative metabolism as an approach to treat heart failure
Natasha Fillmore et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH (2013)
Mitochondrial Complex I Deficiency Increases Protein Acetylation and Accelerates Heart Failure
Georgios Karamanlidis et al.
CELL METABOLISM (2013)
Protein Kinase G Positively Regulates Proteasome-Mediated Degradation of Misfolded Proteins
Mark J. Ranek et al.
CIRCULATION (2013)
Cardiac Metabolism in Heart Failure Implications Beyond ATP Production
Torsten Doenst et al.
CIRCULATION RESEARCH (2013)
Mechanisms of Altered Ca2+ Handling in Heart Failure
Min Luo et al.
CIRCULATION RESEARCH (2013)
Plasma Free Fatty Acids and Risk of Heart Failure The Cardiovascular Health Study
Luc Djousse et al.
CIRCULATION-HEART FAILURE (2013)
Myocardial Titin Hypophosphorylation Importantly Contributes to Heart Failure With Preserved Ejection Fraction in a Rat Metabolic Risk Model
Nazha Hamdani et al.
CIRCULATION-HEART FAILURE (2013)
Effects of carvedilol on heart failure with preserved ejection fraction: the Japanese Diastolic Heart Failure Study (J-DHF)
Kazuhiro Yamamoto et al.
EUROPEAN JOURNAL OF HEART FAILURE (2013)
Galectin-3 in heart failure with preserved ejection fraction
Rudolf A. de Boer et al.
EUROPEAN JOURNAL OF HEART FAILURE (2013)
Increased cGMP promotes healthy expansion and browning of white adipose tissue
Michaela M. Mitschke et al.
FASEB JOURNAL (2013)
Effect of Phosphodiesterase-5 Inhibition on Exercise Capacity and Clinical Status in Heart Failure With Preserved Ejection Fraction A Randomized Clinical Trial
Margaret M. Redfield et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2013)
Metabolic effects of glutamine on the heart: Anaplerosis versus the hexosamine biosynthetic pathway
Benjamin Lauzier et al.
JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY (2013)
Molecular determinants for cardiovascular TRPC6 channel regulation by Ca2+/calmodulin-dependent kinase II
Juan Shi et al.
JOURNAL OF PHYSIOLOGY-LONDON (2013)
A Novel Paradigm for Heart Failure With Preserved Ejection Fraction Comorbidities Drive Myocardial Dysfunction and Remodeling Through Coronary Microvascular Endothelial Inflammation
Walter J. Paulus et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2013)
Impaired Aerobic Capacity and Physical Functional Performance in Older Heart Failure Patients With Preserved Ejection Fraction: Role of Lean Body Mass
Mark J. Haykowsky et al.
JOURNALS OF GERONTOLOGY SERIES A-BIOLOGICAL SCIENCES AND MEDICAL SCIENCES (2013)
Biomarkers in acutely decompensated heart failure with preserved or reduced ejection fraction
Kalkidan Bishu et al.
AMERICAN HEART JOURNAL (2012)
Low Myocardial Protein Kinase G Activity in Heart Failure With Preserved Ejection Fraction
Loek van Heerebeek et al.
CIRCULATION (2012)
A TRPC6-Dependent Pathway for Myofibroblast Transdifferentiation and Wound Healing In Vivo
Jennifer Davis et al.
DEVELOPMENTAL CELL (2012)
Collagen Cross-Linking But Not Collagen Amount Associates With Elevated Filling Pressures in Hypertensive Patients With Stage C Heart Failure Potential Role of Lysyl Oxidase
Begona Lopez et al.
HYPERTENSION (2012)
Increased Proximal Arterial Stiffness and Cardiac Response With Moderate Exercise in Patients With Heart Failure and Preserved Ejection Fraction
Lamia Tartiere-Kesri et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2012)
CaMKII determines mitochondrial stress responses in heart
Mei-ling A. Joiner et al.
NATURE (2012)
Prevalence and Significance of Alterations in Cardiac Structure and Function in Patients With Heart Failure and a Preserved Ejection Fraction
Michael R. Zile et al.
CIRCULATION (2011)
Deletion of Cardiomyocyte Mineralocorticoid Receptor Ameliorates Adverse Remodeling After Myocardial Infarction
Daniela Fraccarollo et al.
CIRCULATION (2011)
Cardiac Inflammation Contributes to Changes in the Extracellular Matrix in Patients With Heart Failure and Normal Ejection Fraction
Dirk Westermann et al.
CIRCULATION-HEART FAILURE (2011)
HDAC3-dependent Reversible Lysine Acetylation of Cardiac Myosin Heavy Chain Isoforms Modulates Their Enzymatic and Motor Activity
Sadhana A. Samant et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2011)
Decreased Cardiac Functional Reserve in Heart Failure With Preserved Systolic Function
Holly S. Norman et al.
JOURNAL OF CARDIAC FAILURE (2011)
High-carbohydrate High-fat Diet-induced Metabolic Syndrome and Cardiovascular Remodeling in Rats
Sunil K. Panchal et al.
JOURNAL OF CARDIOVASCULAR PHARMACOLOGY (2011)
CaMKII in myocardial hypertrophy and heart failure
Mark E. Anderson et al.
JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY (2011)
Diastolic Tissue Doppler Indexes Correlate With the Degree of Collagen Expression and Cross-Linking in Heart Failure and Normal Ejection Fraction
Mario Kasner et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2011)
Early development of intracellular calcium cycling defects in intact hearts of spontaneously hypertensive rats
Sunil Kapur et al.
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY (2010)
Inhibition of TRPC6 Channel Activity Contributes to the Antihypertrophic Effects of Natriuretic Peptides-Guanylyl Cyclase-A Signaling in the Heart
Hideyuki Kinoshita et al.
CIRCULATION RESEARCH (2010)
Impaired Heart Rate Recovery and Chronotropic Incompetence in Patients With Heart Failure With Preserved Ejection Fraction
Thanh Trung Phan et al.
CIRCULATION-HEART FAILURE (2010)
Analysis of Metabolic Remodeling in Compensated Left Ventricular Hypertrophy and Heart Failure
Takao Kato et al.
CIRCULATION-HEART FAILURE (2010)
Filling Pressures and Collagen Metabolism in Hypertensive Patients With Heart Failure and Normal Ejection Fraction
Arantxa Gonzalez et al.
HYPERTENSION (2010)
Exogenous NAD Blocks Cardiac Hypertrophic Response via Activation of the SIRT3-LKB1-AMP-activated Kinase Pathway
Vinodkumar B. Pillai et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2010)
Cyclic GMP/PKG-dependent inhibition of TRPC6 channel activity and expression negatively regulates cardiomyocyte NFAT activation Novel mechanism of cardiac stress modulation by PDE5 inhibition
Norimichi Koitabashi et al.
JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY (2010)
Global Cardiovascular Reserve Dysfunction in Heart Failure With Preserved Ejection Fraction
Barry A. Borlaug et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2010)
Myocardial Fatty Acid Metabolism in Health and Disease
Gary D. Lopaschuk et al.
PHYSIOLOGICAL REVIEWS (2010)
cGMP-Dependent Protein Kinases and cGMP Phosphodiesterases in Nitric Oxide and cGMP Action
Sharron H. Francis et al.
PHARMACOLOGICAL REVIEWS (2010)
Protein Kinase G Modulates Human Myocardial Passive Stiffness by Phosphorylation of the Titin Springs
Martina Krueger et al.
CIRCULATION RESEARCH (2009)
Characterization of the inflammatory and fibrotic response in a mouse model of cardiac pressure overload
Ying Xia et al.
HISTOCHEMISTRY AND CELL BIOLOGY (2009)
Diabetes mellitus accelerates left ventricular diastolic dysfunction through activation of the renin-angiotensin system in hypertensive rats
Shigefumi Fukui et al.
HYPERTENSION RESEARCH (2009)
Contractility and Ventricular Systolic Stiffening in Hypertensive Heart Disease Insights Into the Pathogenesis of Heart Failure With Preserved Ejection Fraction
Barry A. Borlaug et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2009)
Heart Failure With Preserved Ejection Fraction Is Characterized by Dynamic Impairment of Active Relaxation and Contraction of the Left Ventricle on Exercise and Associated With Myocardial Energy Deficiency
Thanh T. Phan et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2009)
Pulmonary Hypertension in Heart Failure With Preserved Ejection Fraction A Community-Based Study
Carolyn S. P. Lam et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2009)
Cyclic GMP Kinase and RhoA Ser188 Phosphorylation Integrate Pro- and Antifibrotic Signals in Blood Vessels
Naoki Sawada et al.
MOLECULAR AND CELLULAR BIOLOGY (2009)
A redox-dependent pathway for regulating class IIHDACs and cardiac hypertrophy
Tetsuro Ago et al.
CELL (2008)
Regulator of G-protein signaling subtype 4 mediates antihypertrophic effect of locally secreted natriuretic peptides in the heart
Takeshi Tokudome et al.
CIRCULATION (2008)
Diastolic stiffness of the failing diabetic heart - Importance of fibrosis, advanced glycation end products, and myocyte resting tension
Loek van Heerebeek et al.
CIRCULATION (2008)
Hypertension-induced remodeling of cardiac excitation-contraction coupling in ventricular myocytes occurs prior to hypertrophy development
Ye Chen-Izu et al.
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY (2007)
Control of in vivo contraction/relaxation kinetics by myosin binding protein C: Protein kinase A phosphorylation-dependent and -independent regulation
Takahiro Nagayama et al.
CIRCULATION (2007)
Impact of arterial load and loading sequence on left ventricular tissue velocities in humans
Barry A. Borlaug et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2007)
Role of oxidative stress in cardiac hypertrophy and remodeling
Eiki Takimoto et al.
HYPERTENSION (2007)
Therapeutic effects of angiotensin II type 1 receptor blocker at an advanced stage of hypertensive diastolic heart failure
Mayu Nishio et al.
JOURNAL OF HYPERTENSION (2007)
Cardiovascular features of heart failure with preserved ejection fraction versus nonfailing hypertensive left ventricular hypertrophy in the urban Baltimore community - The role of atrial remodeling/dysfunction
Vojtech Melenovsky et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2007)
TRPC6 fulfills a calcineurin signaling circuit during pathologic cardiac remodeling
Koichiro Kuwahara et al.
JOURNAL OF CLINICAL INVESTIGATION (2006)
Impaired chronotropic and vasodilator reserves limit exercise capacity in patients with heart failure and a preserved ejection fraction
Barry A. Borlaug et al.
CIRCULATION (2006)
Trends in prevalence and outcome of heart failure with preserved ejection fraction
Theophilus E. Owan et al.
NEW ENGLAND JOURNAL OF MEDICINE (2006)
Suppression of class I and II histone deacetylases blunts pressure-overload cardiac hypertrophy
Yongli Kong et al.
CIRCULATION (2006)
Myocardial structure and function differ in systolic and diastolic heart failure
L van Heerebeek et al.
CIRCULATION (2006)
Selective loss of fine tuning of Gq/11 signaling by RGS2 protein exacerbates cardiomyocyte hypertrophy
W Zhang et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2006)
Beneficial effect of candesartan on rat diastolic heart failure
R Wake et al.
JOURNAL OF PHARMACOLOGICAL SCIENCES (2005)
Dynamics of flow velocities in endocardial and epicardial coronary arterioles
E Toyota et al.
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY (2005)
Transcriptional coactivator PGC-1α controls the energy state and contractile function of cardiac muscle
Z Arany et al.
CELL METABOLISM (2005)
Ventricular structure and function in aged dogs with renal hypertension - A model of experimental diastolic heart failure
VK Munagala et al.
CIRCULATION (2005)
Is plasma cardiotrophin-1 a marker of hypertensive heart disease?
B López et al.
JOURNAL OF HYPERTENSION (2005)
Cardiomyocyte stiffness in Diastolic heart failure
A Borbély et al.
CIRCULATION (2005)
Chronic inhibition of cyclic GMP phosphodiesterase 5A prevents and reverses cardiac hypertrophy
E Takimoto et al.
NATURE MEDICINE (2005)
Paradoxical downregulation of the glucose oxidation pathway despite enhanced flux in severe heart failure
B Lei et al.
JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY (2004)
AT1 receptor blocker added to ACE inhibitor provides benefits at advanced stage of hypertensive diastolic heart failure
J Yoshida et al.
HYPERTENSION (2004)
Combined ventricular systolic and arterial stiffening in patients with heart failure and preserved ejection fraction - Implications for systolic and diastolic reserve limitations
M Kawaguchi et al.
CIRCULATION (2003)
Absolute concentrations of high-energy phosphate metabolites in normal, hypertrophied, and failing human myocardium measured noninvasively with 31P-SLOOP magnetic resonance spectroscopy
M Beer et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2002)
Class II histone deacetylases act as signal-responsive repressors of cardiac hypertrophy
CL Zhang et al.
CELL (2002)
Altered myocardial fatty acid and glucose metabolism in idiopathic dilated cardiomyopathy
VG Dávila-Román et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2002)
Role of cyclic GMP-denendent protein kinase in the contractile response to exogenous nitric oxide in rat cardiac myocytes
J Layland et al.
JOURNAL OF PHYSIOLOGY-LONDON (2002)
Absence of pressure overload induced myocardial hypertrophy after conditional inactivation of Gαq/Gα11 in cardiomyocytes
N Wettschureck et al.
NATURE MEDICINE (2001)
cGMP-dependent protein kinase phosphorylates and inactivates RhoA
N Sawada et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2001)
Physiology of nitric oxide in skeletal muscle
JS Stamler et al.
PHYSIOLOGICAL REVIEWS (2001)
Time-course changes in left ventricular geometry and function during the development of hypertension in Dahl salt-sensitive rats
P Qu et al.
HYPERTENSION RESEARCH (2000)
Roles of renin-angiotensin and endothelin systems in development of diastolic heart failure in hypertensive hearts
K Yamamoto et al.
CARDIOVASCULAR RESEARCH (2000)
nNOS and eNOS modulate cGMP formation and vascular response in contracting fast-twitch skeletal muscle
KS Lau et al.
PHYSIOLOGICAL GENOMICS (2000)
Renal function and structure in diabetic, hypertensive, obese ZDFxSHHF-hybrid rats
SP Tofovic et al.
RENAL FAILURE (2000)
Development of different phenotypes of hypertensive heart failure: systolic versus diastolic failure in Dahl salt-sensitive rats
R Doi et al.
JOURNAL OF HYPERTENSION (2000)
Share Paper
